Finance

Lists
Why is SDGR down 7,35%?
Dive Deeper
SDGR:NASDAQ
Schrodinger Inc
USD 27,36
-7,35%
(-2,17) 1D
USD 27,16
-0,73% (-0,20)
After hours
Closed: 16 Nov., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SDGR...
Open
USD 28,78
High
USD 28,86
Low
USD 27,20
Mkt. cap
2,05 mjd
Avg. vol.
2,10 m
Volume
1,20 m
52-wk high
USD 34,00
52-wk low
USD 10,95
EPS
-USD 0,79
Beta
1,69
Shares outstanding
65,91 m
No. of employees
850
Open
USD 28,78
High
USD 28,86
Low
USD 27,20
Mkt. cap
2,05 mjd
Avg. vol.
2,10 m
Volume
1,20 m
52-wk high
USD 34,00
52-wk low
USD 10,95
EPS
-USD 0,79
Beta
1,69
Shares outstanding
65,91 m
No. of employees
850
News stories
From web sources and news partners
Profile
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market. Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
About Schrodinger Inc
CEORamy Farid
Employees850
Founded1990
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to SDGR in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SDGR in the last 3 months.
Highest
Current USD 27,36
USD 36,00 (+31,58%)
Average
USD 32,40 (+18,42%)
Lowest
USD 29,00 (+5,99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lu Li
Bank of America Securities
Buy
Maintained
-
-
11/10/2026
Kevin Caliendo
UBS
Hold
Maintained
USD 30,00
+9,6%
11/06/2026
Brendan Smith
TD Cowen
Buy
Maintained
USD 36,00
+31,6%
11/05/2026
Sean Laaman
Morgan Stanley
Hold
Reiterated
USD 29,00
+6%
11/05/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
USD 29,00
+6%
11/05/2026
Evan Seigerman
BMO Capital
Buy
Reiterated
USD 35,00
+27,9%
11/05/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
USD 32,00
+17%
10/16/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
-
-
08/06/2026
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
07/08/2026
Michael Yee
UBS
Hold
Reiterated
USD 13,00
-52,5%
03/17/2026
Last report
04 Nov. 2026
Fiscal period
Q3 2026
-USD 0,50 / -USD 0,52
+3,85%beat
Revenue / Est. (USD)
64,49 m / 47,63 m
+35,39%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
87,24 m
58,59 m
58,89 m
64,49 m
Cost of goods sold
29,94 m
29,04 m
26,46 m
26,24 m
Cost of revenue
29,94 m
29,04 m
26,46 m
26,24 m
Research and development expenses
41,40 m
43,82 m
41,00 m
34,09 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,05 m
34,52 m
32,98 m
30,29 m
Operating expense
74,45 m
78,34 m
73,98 m
64,38 m
Total operating expenses
104,39 m
107,38 m
100,44 m
90,62 m
Operating income
-17,16 m
-48,79 m
-41,55 m
-26,13 m
Other non operating income
3,13 m
2,66 m
3,03 m
3,33 m
EBT including unusual items
32,97 m
-59,62 m
7,35 m
-37,56 m
EBT excluding unusual items
-14,03 m
-46,13 m
-38,52 m
-22,80 m
Income tax expense
462,00 k
408,00 k
1,37 m
156,00 k
Effective tax rate
1,40%
-0,68%
18,67%
-0,42%
Other operating expenses
-
-
-
-
Net income
32,51 m
-60,03 m
5,98 m
-37,71 m
Net profit margin
37,27%
-102,46%
10,15%
-58,47%
Earnings per share
-0,18
-0,62
-0,42
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-15,72 m
-47,32 m
-40,06 m
-24,67 m
Gain or loss from assets sale
-
11,00 k
-12,00 k
-6,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google-programme